HGH Fragment, Modified GRF, Ipamorelin

Also known as HGH Fragment 176-191, hGH Frag 176-191, growth hormone fragment, lipolytic fragment

HGH Fragment 176-191 combined with Modified GRF (CJC-1295 No DAC) and Ipamorelin creates a triple-action body recomposition system that burns fat aggressively while preserving muscle and amplifying growth hormone at multiple levels. The Fragment targets the specific fat-burning region of growth hormone without affecting blood sugar or hormones, Modified GRF triggers natural pulsatile GH release mimicking your body’s youthful pattern, and Ipamorelin amplifies those pulses cleanly.

Route

Subcutaneous injection

Dose range

100 mcg – 500 mcg

Frequency

Frag 1-2x daily; GHRH/GHRP 1x daily

Cycle length

8–12 weeks

Not currently stocked by N1 Aminos. Browse what is in stock →

Overview

HGH Fragment 176-191 combined with Modified GRF (CJC-1295 No DAC) and Ipamorelin creates a triple-action body recomposition system that burns fat aggressively while preserving muscle and amplifying growth hormone at multiple levels. The Fragment targets the specific fat-burning region of growth hormone without affecting blood sugar or hormones, Modified GRF triggers natural pulsatile GH release mimicking your body’s youthful pattern, and Ipamorelin amplifies those pulses cleanly. Together they can boost GH 10-fold or more, creating dramatic lean tissue gains while melting stubborn belly and thigh fat—results that diet and exercise alone rarely achieve.

The synergistic power lies in three complementary mechanisms converging on optimal body recomposition: Fragment 176-191 directly mobilizes fat for energy, Modified GRF and Ipamorelin elevate anabolic hormones supporting muscle preservation and collagen synthesis. Studies show this blend preserves lean mass during aggressive fat loss better than any single peptide, with users reporting visible abs, fullness in muscles, and transformed composition within 8-12 weeks. Enhanced recovery, deeper sleep, improved cognition, and metabolic flexibility are bonus perks. Ideal for competitive athletes, physique competitors, or anyone hitting a body recomposition wall, nightly injections align with natural GH windows for compounding benefits.

Studied benefits

  • This stack focuses on aggressive fat oxidation (HGH Fragment) combined with a highly controlled GH pulse (Modified GRF + Ipamorelin)
  • It is effective for body recomposition and metabolic health without significantly affecting blood sugar or appetite

Reported side effects

  • Generally well-tolerated
  • potential for a temporary "head rush" or flushing immediately after administration and minor swelling at the site of injection

Protocol

Dosing Schedule (Subcutaneous)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

HGH Frag 176-191 + Mod GRF + Ipamorelin Blend

Reconstitute with 3.0 mL bacteriostatic water for precise multi-peptide measurement.

Investigating the combined effect of direct lipolysis (Fragment) and GHRH/GHRP synergy (Mod GRF/Ipamorelin) on adipose tissue reduction.

PeptideStandard DoseDraw at 2.5 mg/mLLog
HGH Fragment250–500 mcg20 units (0.2 mL)+ Log
Mod GRF / Ipamorelin100 mcg each4 units (0.04 mL)+ Log

Frequency

Frag 1-2x daily; GHRH/GHRP 1x daily.

Timing

Must be administered on an empty stomach to avoid insulin interference.

Cycle length

8–12 weeks.

Unit calculator

Set your vial and water; the table above updates.

Open the full calculator →
Concentration

2.5 mg/mL

10 doses of 500 mcg per vial

At the starting dose (500 mcg × 14/week for a 8-week cycle) you would use about 56 mg, i.e. 12 × 5 mg vials. Higher phases use proportionally more.

Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.

Context

Lifestyle considerations

Follow a nutrient-dense, balanced diet with a focus on timing; the fat-burning effects of the Fragment are significantly enhanced when insulin levels are low. Combine this protocol with regular cardiovascular activity and strength training to capitalize on the improved recovery and metabolic rate. Ensure 7–9 hours of quality sleep to facilitate the deep-recovery processes driven by the growth hormone axis. Maintain optimal hydration and manage stress, as elevated cortisol can counteract the lipolytic benefits and metabolic efficiency of this potent three-part peptide combination.

Evidence

Research summaries

Modified GRF (CJC No DAC) and Ipamorelin Synergy with HGH Frag for Lipolysis

Findings: Enhanced fat mobilization, preserved muscle during cuts, optimized GH/IGF axis.

Modified GRF (CJC shorthand) extends GH pulses; Ipamorelin cleans them; Frag burns fat directly. Combo mimics natural rhythm, spiking lipolysis post-lag. Superior to singles for body comp.

Read the study ↗
More references (5)

Identification

Chemistry

common names
HGH Fragment 176-191, hGH Fragment 176-191, hGH Frag 176-191, growth hormone fragment, lipolytic fragment, fat-burning peptide, AOD9604 analog; Modified GRF (1-29), Mod GRF (1-29), CJC-1295 (No DAC), CJC-1295 without DAC, Modified GHRH (1-29), GRF (1-29) analog, pulsatile CJC-1295, MOD-GRF; Ipamorelin, NNC-26-0161, selective GHS-R1a agonist, growth hormone secretagogue, GHS; Blend Designation: HGH Fragment 176-191/Modified GRF (1-29)/Ipamorelin blend, Fragment 176-191/Mod GRF/Ipamorelin combination, Fragment/GHRH/GHS triple peptide blend, three-component lipolytic and growth hormone secretagogue blend
cas
66004-57-7
formula
C₇₈H₁₂₃N₂₃O₂₂S₂
molecular weight
1,799.08–1,799.10 Da (g/mol)
sequence
Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (with disulfide bridge between Cys7 and Cys14)
source
Synthetic (laboratory-manufactured)
biosynthesis
Non-ribosomal synthesis via chemical peptide synthesis; derived from C-terminal sequence of hGH
type
Linear peptide with internal disulfide bond linking cysteines at positions 7 and 14, creating cyclic structural constraint

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor